分组1 - UnitedHealth's Q4 earnings release triggered a significant sell-off across the healthcare industry, impacting companies like Centene, which has notable exposure to governmental healthcare programs, albeit less than UnitedHealth [1] - The sell-off reflects broader market concerns regarding the performance and outlook of healthcare stocks following UnitedHealth's results [1] 分组2 - The article emphasizes the importance of fundamental analysis in making informed investment decisions, highlighting the author's experience in managing a family portfolio and understanding the balance between risk and reward [1] - The author aims to provide accessible insights for investors of all experience levels, leveraging a background in IT to navigate complexities in technology stocks while also exploring diverse sectors for investment opportunities [1]

After UnitedHealth's ( UNH ) yesterday Q4 earnings release, the entire industry suffered a big panic sell-off. Despite Centene's ( CNC ) exposure to governmental healthcare programs is not as significant as UNH's, it is still notable, andComing from an IT background, I have dived into the U.S. stock market seven years ago by managing portfolio of my family. Starting managing real money has been challenging for the first time, but long hours of mastering fundamental analysis of public companies paid off and ...

格隆汇1月28日｜摩根士丹利：将联合健康(UNH.US)目标价从409美元下调至375美元。 ...

U.S. stock markets are poised for a pivotal Wednesday, January 28th, 2026, as investors keenly await the Federal Reserve's latest interest rate decision and a flurry of earnings reports from influential technology giants. Premarket trading indicates a mixed but generally upward trend for futures, with the tech-heavy Nasdaq leading the charge, signaling continued optimism in the artificial intelligence (AI) sector.Premarket Activity and Futures MovementsAs the trading day begins to unfold, U.S. stock index f ...

CHONGQING, CHINA - JANUARY 22: In this photo illustration, a smartphone displays the logo of UnitedHealth Group (NYSE: UNH), an American multinational healthcare company providing health insurance services and healthcare solutions through its UnitedHealthcare and Optum businesses, in front of a screen showing the company's latest stock market chart on January 22, 2026, in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)Getty ImagesUnitedHealth Group (NYSE: UNH) announced its Q4 2025 earnings ...

Core Insights - UnitedHealth Group reported a 16% decline in net earnings for 2025, falling to $12.1 billion from $14.4 billion in 2024, primarily due to Medicare funding reductions and costs associated with the Change Healthcare cyberattack [1] - The adjusted medical care ratio increased to 88.9% in 2025, up from 85.5% in the previous year, indicating rising medical costs [2] - Total revenue for 2025 rose by 12% to $447.5 billion, compared to $400.2 billion in 2024, reflecting growth across various segments [2] Revenue Segments - The UnitedHealthcare Medicare & Retirement segment saw revenues increase by 23% to $171.3 billion, attributed to a rise in the number of individuals served and the Inflation Reduction Act Part D provisions [3] - The Community & State division experienced a 17% year-on-year revenue growth, reaching $94.4 billion, driven by increased services for individuals with complex needs and higher Medicaid rates [3] - The UnitedHealthcare Employer & Individual segment reported a slight revenue increase to $79.2 billion from $78.2 billion in the previous year [2] Quarterly Performance - In Q4, net earnings attributable to shareholders dropped to $10 million from $5.5 billion a year earlier, while quarterly revenues increased to $113.2 billion from $100.8 billion [4] - Guidance for 2026 projects revenues to be above $439 billion, reflecting a 2% decrease due to planned right-sizing across the enterprise, with anticipated earnings from operations exceeding $24 billion and a net margin forecasted near 3.6% [4] Management Commentary - CEO Stephen Hemsley stated that the company faced challenges directly and emerged stronger, positioning itself to better serve its clients and improve core performance [5] - A recent investigation by the US Senate Judiciary Committee alleged that UnitedHealth Group used assertive tactics to secure higher payments for Medicare Advantage members [5][6]

Core Insights - Several U.S. politicians sold UnitedHealth stock shortly before a significant market crash on January 27, 2026, raising concerns about the timing of these transactions [1][6][10] Group 1: Stock Performance and Market Impact - UnitedHealth experienced a dramatic loss of approximately 19% in a single trading session, closing at $282.70, which contributed to a nearly 50% decline in its stock value over the past year [2][9] - The company's market capitalization was significantly affected, erasing tens of billions of dollars and dragging down the Dow Jones Industrial Average [1] Group 2: Revenue Guidance and Financial Concerns - UnitedHealth's revenue guidance for 2026 was projected at about $439 billion, falling short of Wall Street estimates of $454 to $456 billion, which contributed to the stock's decline [9] - Rising medical costs and weaker earnings, along with proposed Medicare Advantage payment increases of only 0.09% for 2027, further exacerbated the situation [9] Group 3: Congressional Stock Transactions - Notable transactions included Rep. Kevin Hern selling UnitedHealth shares valued between $250,001 and $500,000 on December 23, 2025, just weeks before the stock's plunge [3][6] - Rep. Julie Johnson sold shares twice in November and December 2025, with each sale ranging from $1,001 to $15,000, occurring while the stock was still perceived as a defensive play [7] - Rep. Gilbert Cisneros sold shares on November 12, 2025, and later purchased shares on December 19, 2025, shortly before the company's outlook worsened [8]

Piper Sandler高级研究分析师杰西卡.塔桑(Jessica Tassan)表示，在充满挑战的联邦医疗保险优势计划 (Medicare Advantage)费率环境中，联合健康集团(UNH.US)是应对能力最强的公司，其核心原因包括公 司规模庞大的基础设施、深厚的基于价值的医疗业务底蕴，以及对联邦医疗保险这一核心业务的战略坚 守。 这一评估是在医疗保险和医疗补助服务中心(Centers for Medicare and Medicaid Services)发布2027年预估 费率通知后做出的。该通知显示，预计平均收入变化近乎持平，仅为0.09%，与2026年约5%的增幅相比 出现大幅下降。 据了解，由于当前医疗通胀率仍维持在较高水平，这一近乎持平的费率实际上构成了显著的盈利压力。 与此同时，政府计划通过严厉打击"虚增代码"行为来收紧预算，预计到2027年将导致整个保险行业减少 超过70亿美元的收入，这一政策导向直接触发了资本市场的剧烈抛售。 受此冲击，联合健康的股价在2026年1月27日遭遇重挫，跌幅一度接近20%，最终收跌19.61%，市值蒸 发规模创下历史记录。 在接受采访时，塔桑详细阐释了医疗保 ...

加拿大皇家银行(RBC)：将联合健康(UNH.US)目标价从408美元下调至361美元。 ...

政府統計處發表的對外商品貿易統計數字顯示，2025 年 12 月份本港整體出口 和進口貨值均錄得按年升幅，分別上升 26.1%和 30.6%。市場預期分別上升 16.8% 及 19.9% 港股點評 2026年1月28日9:30 a.m 恒指升 361 點，滬指升 7 點，標普 500 升 28 點 外圍股市上升。港股造好。恒指高開 97 點後升幅擴大，曾升 423 點一度高見 27,188 點，全日升 361 點或 1.4%，收 27,126 點；國指升 97 點或 1.1%，收 9,244 點；恒生科指升 28 點或 0.5%，收 5,754 點。大市全日成交總額 2,543.73 億元。 人民幣兌美元中間價按日下調 15 點，報 6,9858 兌一美元。人民銀行 27 日在公 開市場開展 4,020 億元人民幣七天期逆回購操作，操作利率持平於 1.4%。有 3,240 億元逆回購到期，單日淨投放 780 億元。A 股三大指數早市個別發展，午後全 線穩升。滬綜指全日收升 7 點或 0.2%，報 4,139 點，成交 1.29 萬億元。深成指 全日收升 13 點或 0.09%，報 14,329 點，成交 1. ...